LIVONIA – With coronavirus infection rates fluctuating throughout the United States, millions of people with Type 2 diabetes and uncontrolled blood sugar levels remain at elevated risk for serious complications from the disease. In response, physician specialists and scientists from Hygieia have introduced a fully virtual option for their d-Nav® Insulin Management Program.
“Ninety percent of patients using the d-Nav program report significant improvement in blood glucose levels within 90 days of starting,” said Robert Frank, M.D., chief medical officer at Hygieia. “During this crisis, access to Hygieia’s technology and specialty provider support is critical. Now, we can bring safe and effective insulin management, and lower blood sugar levels, to substantially more people.”
Hygieia’s d-Nav program takes the guesswork out of insulin dosing for people who inject daily. It automates insulin dose prescribing using AI and patented technology in an FDA-cleared mobile app. The program includes clinical care support either virtually, or in a Hygieia clinic. The app works by tracking and analyzing each patient’s blood glucose patterns and, based on those patterns, automatically determining how much insulin is needed at the time of injection.
This is a dramatic change from today’s standard of care in which a patient’s insulin treatment plan is modified only when he or she can see a physician for evaluation every few months.
For new patients, Hygieia is taking the onboarding visit to the home. New patients will be mailed a kit with the cloud-connected d-Nav device, lancets and test strips, and instructions on how to use the program. The d-Nav clinical team will speak with patients over a video or audio call to personalize their d-Nav and instruct them on how to begin automating insulin dose recommendations. Hygieia will send patients an A1c blood test they can complete at home and return for analysis.
Hygieia participates with Medicare and private health insurance.
The d-Nav insulin management program was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan. Learn more at hygieia.com.